Prednisone Dosing and Management

Introduction to Prednisone Therapy

The European League Against Rheumatism recommends starting with 12.5-25 mg/day oral prednisone for Polymyalgia Rheumatica (PMR) 1, 2
The American College of Rheumatology suggests using the lower end (12.5 mg/day) in patients with diabetes, osteoporosis, glaucoma, or hypertension to minimize glucocorticoid-related adverse effects 1, 2
The European League Against Rheumatism recommends tapering to 10 mg/day within 4-8 weeks, then reducing by 1 mg every 4 weeks until discontinuation 3

For Rheumatoid Arthritis (RA), the American College of Rheumatology recommends using ≤10 mg/day prednisone for chronic management—doses above this increase harm without additional benefit 4
For Autoimmune Hepatitis, the American Association for the Study of Liver Diseases recommends starting with prednisone 30 mg/day plus azathioprine 50 mg/day 5
For Multiple Sclerosis, there is no recommended dosing due to lack of cited information.

For doses >30 mg/day, the American College of Rheumatology recommends reducing by 10 mg every 2 weeks until reaching 30 mg/day 3
For doses 10-30 mg/day, the American College of Rheumatology recommends tapering by 5 mg every week until reaching 10 mg/day 3
For doses 5-10 mg/day, the European League Against Rheumatism recommends tapering by 1 mg every 4 weeks 1, 2, 3

For patients with diabetes, the American Diabetes Association recommends using lower initial doses (12.5 mg/day for PMR) and monitoring blood glucose closely during therapy 1, 2, 7
For patients with hypertension, the American Heart Association recommends using lower initial doses and monitoring blood pressure regularly 1, 2, 7
For patients with osteoporosis, the National Osteoporosis Foundation recommends mandatory calcium 800-1,000 mg/day and vitamin D 400-800 units/day for all patients on prednisone >7.5 mg/day for >3 months 7, 4

Before initiating therapy, the American College of Rheumatology recommends assessing for hypertension, diabetes, peptic ulcer, recent fractures, cataracts, glaucoma, infections, and dyslipidemia 7
During therapy, the American College of Rheumatology recommends monitoring body weight, blood pressure, serum lipids, blood/urine glucose 7
For therapy >1 month, the American College of Rheumatology recommends adequate glucocorticoid replacement during surgery to prevent adrenal insufficiency 7

If disease flare occurs, the American College of Rheumatology recommends immediately returning to the pre-relapse dose and maintaining for 4-8 weeks until disease control re-established 3
Consider adding steroid-sparing agents (methotrexate, azathioprine) if multiple relapses occur 1, 3

Never stop prednisone abruptly after >3 weeks of therapy—risk of adrenal insufficiency 3
Never taper faster than 1 mg per month when below 10 mg/day—increases relapse risk 4
Never use chronic doses >10 mg/day for RA—increases harm without additional benefit 4
Never fail to provide calcium and vitamin D supplementation for patients on >7.5 mg/day for >3 months 7, 4